Search research articles
Contact Us
Filters
Showing results (51-60 of 188) with videos related to
Page
of 19
Sort By:
Biomarker Research
|
March 27, 2026
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
Hanna Grauers Wiktorin, Viktoria Ekström-Rydén, Ida Ek, et al.
Journal of Translational Medicine
|
April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021
Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Journal of the American Academy of Dermatology
|
May 20, 2020
Improved survival in women versus men with merkel cell carcinoma
Moses Tam, Michael Luu, Christopher A Barker, et al.
Journal of Surgical Oncology
|
April 17, 2020
The association between facility volume and overall survival in patients with Merkel cell carcinoma
Emi J Yoshida, Michael Luu, Morganna Freeman, et al.
American Journal of Clinical Oncology
|
July 24, 2019
Association Between Smoking and Survival Benefit of Immunotherapy in Advanced Malignancies: A Systematic Review and Meta-Analysis
Christopher J D Wallis, Raj Satkunasivam, Mohit Butaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
Jedd D Wolchok, Axel Hoos, Steven O'Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2020
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
Michele Maio, Omid Hamid, James Larkin, et al.
The Oncologist
|
July 9, 2025
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors
Martin E Gutierrez, Shou-Ching Tang, John D Powderly, et al.
Cancer Immunity
|
October 21, 2010
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials
Jedd D Wolchok, Jeffrey S Weber, Omid Hamid, et al.
Cancer Immunology, Immunotherapy : CII
|
December 8, 2011
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji, Scott D Chasalow, Lisu Wang, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 188) with videos related to
Sort By:
Page
of 19
Biomarker Research
|
March 27, 2026
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
Hanna Grauers Wiktorin, Viktoria Ekström-Rydén, Ida Ek, et al.
Journal of Translational Medicine
|
April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021
Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Journal of the American Academy of Dermatology
|
May 20, 2020
Improved survival in women versus men with merkel cell carcinoma
Moses Tam, Michael Luu, Christopher A Barker, et al.
Journal of Surgical Oncology
|
April 17, 2020
The association between facility volume and overall survival in patients with Merkel cell carcinoma
Emi J Yoshida, Michael Luu, Morganna Freeman, et al.
American Journal of Clinical Oncology
|
July 24, 2019
Association Between Smoking and Survival Benefit of Immunotherapy in Advanced Malignancies: A Systematic Review and Meta-Analysis
Christopher J D Wallis, Raj Satkunasivam, Mohit Butaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
Jedd D Wolchok, Axel Hoos, Steven O'Day, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2020
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
Michele Maio, Omid Hamid, James Larkin, et al.
The Oncologist
|
July 9, 2025
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors
Martin E Gutierrez, Shou-Ching Tang, John D Powderly, et al.
Cancer Immunity
|
October 21, 2010
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials
Jedd D Wolchok, Jeffrey S Weber, Omid Hamid, et al.
Cancer Immunology, Immunotherapy : CII
|
December 8, 2011
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji, Scott D Chasalow, Lisu Wang, et al.
Page
of 19